NARA Discovery
Article Details
← Back to Search Results
Journal Article

Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene

Kinga Gawel; Waldemar A. Turski; Wietske van der Ent; Benan J. Mathai; Karolina J. Kirstein-Smardzewska; Anne Simonsen; Camila V. Esguerra
Molecular Neurobiology · Vol. 57, Issue 4 · pp. 1904-1916 · 2020

Abstract

The CACNA1A gene encodes the pore-forming α1 subunit of voltage-gated P/Q type Ca 2+ channels (Ca v 2.1). Mutations in this gene, among others, have been described in patients and rodents suffering from absence seizures and episodic ataxia type 2 with/without concomitant seizures. In this study, we aimed for the first time to assess phenotypic and behavioral alterations in larval zebrafish with partial cacna1aa knockdown, placing special emphasis on changes in epileptiform-like electrographic discharges in larval brains. Whole-mount in situ hybridization analysis revealed expression of cacna1aa in the optic tectum and medulla oblongata of larval zebrafish at 4 and 5 days post-fertilization. Next, microinjection of two antisense morpholino oligomers (individually or in combination) targeting all splice variants of cacna1aa into fertilized zebrafish eggs resulted in dose-dependent mortality and decreased or absent touch response. Over 90% knockdown of cacna1aa on protein level induced epileptiform-like discharges in the optic tectum of larval zebrafish brains. Incubation of morphants with antiseizure drugs (sodium valproate, ethosuximide, lamotrigine, topiramate) significantly decreased the number and, in some cases, cumulative duration of epileptiform-like discharges. In this context, sodium valproate seemed to be the least effective. Carbamazepine did not affect the number and duration of epileptiform-like discharges. Altogether, our data indicate that cacna1aa loss-of-function zebrafish may be considered a new model of absence epilepsy and may prove useful both for the investigation of Cacna1a -mediated epileptogenesis and for in vivo drug screening.

Bibliographic Information

JournalMolecular Neurobiology
PublisherSpringer
Publication Date2020-04-01
Publication Year2020
Volume57
Issue4
Pages1904-1916
Document TypeJournal Article
Print ISSN0893-7648
eISSN1559-1182
DOI10.1007/s12035-019-01860-x

Access Information

NARA Access Coverage1987-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12035
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.